abstract |
The present invention relates to formulations of 3-(6-(1-(2,2-difluorobenzo [d][1,3 ]dioxol-5 -yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid in Form I, pharmaceutical packs or kits thereof, and methods of treatment therewith. |